HU-345

HU-345 (cannabinol quinone) is a drug that is able to inhibit aortic ring angiogenesis more potently than its parent compound cannabinol.[1][2]

HU-345
Identifiers
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC21H24O3
Molar mass324.414 g/mol g·mol−1
3D model (JSmol)
  (verify)

See also

References

  1. Natalya M. Kogan; et al. (2006). "A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells". Molecular Pharmacology. 70 (1): 51–59. doi:10.1124/mol.105.021089. PMID 16571653.
  2. US patent 0092584, Mechoulam R, Kogan NM, Rabinowitz R, Schlesinger M, "Therapeutic Use of Quinonoid Derivatives of Cannabinoids", granted 2011-04-21
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.